CD81 binding regions of hepatitis C virus remain conserved after liver transplantation

by Andre C. Lyra, Xiaofeng Fan, Adrian M. Di Bisceglie

A novel target enrichment strategy in next-generation sequencing through 7-deaza-dGTP-resistant enzymatic digestion

by Peng Peng, Yanjuan Xu, Adrian M. Di Bisceglie, Xiaofeng Fan
Published 2020-09-01

Inhibition of c3 convertase activity by hepatitis C virus as an additional lesion in the regulation of complement components.

by Hangeun Kim, Keith Meyer, Adrian M Di Bisceglie, Ranjit Ray
Published 2014-01-01

Genome-wide capture sequencing to detect hepatitis C virus at the end of antiviral therapy

by Peng Peng, Yanjuan Xu, Michael W. Fried, Adrian M. Di Bisceglie, Xiaofeng Fan
Published 2020-08-01

Pharmacokinetics and pharmacodynamics of HTD1801 (berberine ursodeoxycholate, BUDCA) in patients with hyperlipidemia

by Adrian M. Di Bisceglie, Gerald F. Watts, Philip Lavin, Meng Yu, Ru Bai, Liping Liu
Published 2020-11-01

High-resolution quantification of hepatitis C virus genome-wide mutation load and its correlation with the outcome of peginterferon-alpha2a and ribavirin combination therapy.

by Weihua Wang, Xiaoan Zhang, Yanjuan Xu, George M Weinstock, Adrian M Di Bisceglie, Xiaofeng Fan
Published 2014-01-01

Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma.

by Mary Ann Comunale, Lucy Rodemich-Betesh, Julie Hafner, Mengjun Wang, Pamela Norton, Adrian M Di Bisceglie, Timothy Block, Anand Mehta
Published 2010-08-01

A phase 2, proof of concept, randomised controlled trial of berberine ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetes

by Stephen A. Harrison, Nadege Gunn, Guy W. Neff, Anita Kohli, Liping Liu, Abbey Flyer, Lawrence Goldkind, Adrian M. Di Bisceglie
Published 2021-09-01

Contribution of genome-wide HCV genetic differences to outcome of interferon-based therapy in Caucasian American and African American patients.

by Maureen J Donlin, Nathan A Cannon, Rajeev Aurora, Jia Li, Abdus S Wahed, Adrian M Di Bisceglie, John E Tavis, Virahep-C Study Group
Published 2010-02-01

Altered functionality of anti-bacterial antibodies in patients with chronic hepatitis C virus infection.

by Anne Lamontagne, Ronald E Long, Mary Ann Comunale, Julie Hafner, Lucy Rodemich-Betesh, Mengjun Wang, Jorge Marrero, Adrian M Di Bisceglie, Timothy Block, Anand Mehta
Published 2013-01-01

A Real‐World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET‐HCC

by Roniel Cabrera, Amit G. Singal, Massimo Colombo, R. Kate Kelley, Hannah Lee, Andrea R. Mospan, Tim Meyer, Pippa Newell, Neehar D. Parikh, Bruno Sangro, K. Rajender Reddy, Stephanie Watkins, Richard C. Zink, Adrian M. Di Bisceglie
Published 2021-03-01

Treatment Status of Hepatocellular Carcinoma Does Not Influence Rates of Sustained Virologic Response: An HCV‐TARGET Analysis

by Kavita Radhakrishnan, Adrian M. Di Bisceglie, K. Rajender Reddy, Joseph K. Lim, Josh Levitsky, Mohamed A. Hassan, Jama M. Darling, Jordan J. Feld, Lucy Akushevich, Monika Vainorius, David R. Nelson, Michael W. Fried, Robert S. Brown Jr., Norah A. Terrault
Published 2019-10-01

A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic h...

by Donna M Evon, Paul W Stewart, Jipcy Amador, Marina Serper, Anna S Lok, Richard K Sterling, Souvik Sarkar, Carol E Golin, Bryce B Reeve, David R Nelson, Nancy Reau, Joseph K Lim, K Rajender Reddy, Adrian M Di Bisceglie, Michael W Fried
Published 2018-01-01